Literature DB >> 23794139

Fatty acid profile of cardiac muscle phospholipid and triacylglycerol in MDX mice and C57BL/10ScSnJ controls.

Marc A Tuazon1, Gregory C Henderson.   

Abstract

The mdx mouse is a model for Duchenne muscular dystrophy (DMD), a debilitating disease affecting striated muscle. It is established that the fatty acid (FA) composition of skeletal muscle phospholipid (PL) is altered in mdx mice, but it is not known if cardiac muscle is similarly affected by dystrophin-deficiency. We tested FA profiles in PL and triacylglycerol (TAG) in cardiac muscle of 12-week old mdx and control (con) mice. Of 22 different FA, similar to our previous finding for skeletal muscle, the most abundant FA in heart PL were palmitic, stearic, cis-vaccenic, linoleic, and docosahexaenoic acid, while for TAG the most abundant FA were palmitic, oleic, cis-vaccenic, and linoleic acid. In comparing mdx and con, no significant group differences were detected for any FA in PL or TAG. Thus, unlike skeletal muscle, FA composition in cardiac muscle PL is not different between mdx and con at the age studied. The results can be understood in the context of tissue-specific disease severity in mdx mice, as pathology is quite modest in cardiac compared with skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794139     DOI: 10.1007/s11745-013-3811-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  10 in total

1.  Fatty acid profile of skeletal muscle phospholipid is altered in mdx mice and is predictive of disease markers.

Authors:  Marc A Tuazon; Gregory C Henderson
Journal:  Metabolism       Date:  2011-12-28       Impact factor: 8.694

2.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.

Authors:  K A Frankel; R J Rosser
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

3.  Timeline of cardiac dystrophy in 3-18-month-old MDX mice.

Authors:  Christel Van Erp; David Loch; Nicola Laws; Andrea Trebbin; Andrew J Hoey
Journal:  Muscle Nerve       Date:  2010-10       Impact factor: 3.217

4.  Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging.

Authors:  David Touboul; Hélène Piednoël; Vincent Voisin; Sabine De La Porte; Alain Brunelle; Frédéric Halgand; Olivier Laprévote
Journal:  Eur J Mass Spectrom (Chichester)       Date:  2004       Impact factor: 1.067

5.  Separation of positional and geometrical fatty acid isomers as 2-nitrophenylhydrazide derivatives by high-performance liquid chromatography.

Authors:  Gregory C Henderson; Marc A Tuazon
Journal:  Anal Biochem       Date:  2011-02-13       Impact factor: 3.365

6.  Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.

Authors:  Wei Li; Wei Liu; Jia Zhong; Xin Yu
Journal:  J Cardiovasc Magn Reson       Date:  2009-10-22       Impact factor: 5.364

7.  Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging.

Authors:  Nora Tahallah; Alain Brunelle; Sabine De La Porte; Olivier Laprévote
Journal:  J Lipid Res       Date:  2007-11-17       Impact factor: 5.922

8.  MALDI reveals membrane lipid profile reversion in MDX mice.

Authors:  Farida Benabdellah; Hua Yu; Alain Brunelle; Olivier Laprévote; Sabine De La Porte
Journal:  Neurobiol Dis       Date:  2009-07-24       Impact factor: 5.996

9.  Green tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx mice.

Authors:  Nicholas P Evans; Jarrod A Call; Josep Bassaganya-Riera; John L Robertson; Robert W Grange
Journal:  Clin Nutr       Date:  2009-11-07       Impact factor: 7.324

10.  Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age.

Authors:  S Messina; G L Vita; M Aguennouz; M Sframeli; S Romeo; C Rodolico; G Vita
Journal:  Acta Myol       Date:  2011-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.